Healthcare provider profile · identity verified

Isaac Zoller

Allopathic & Osteopathic Physicians|Family Medicine · ST LOUIS PARK, MN · NPI 1295180628

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Isaac Zoller received $36.57 in general payments during 2025 across 2 reported records.

Abbott Laboratories accounted for 51.9% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 2 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$36.57

2 reported records · 2 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Abbott Laboratories	Unresolved — no canonical attribution shown	$18.97	51.9%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$17.60	48.1%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$36.57	2

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
FREESTYLE LIBRE 3 Normalized: freestyle libre 3	Device	Abbott Laboratories	$18.97	1	2025
Source payment records 2025-03-04 · Abbott Laboratories · $18.97 · Open Payments source
The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit	Device	Exact Sciences Corporation	$17.60	1	2025
Source payment records 2025-03-25 · Exact Sciences Corporation · $17.60 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	906	274
Levothyroxine Sodium	Levothyroxine Sodium	521	154
Lisinopril	Lisinopril	481	152
Losartan Potassium	Losartan Potassium	350	105
Amlodipine Besylate	Amlodipine Besylate	339	108
Gabapentin	Gabapentin	339	111
Tamsulosin Hcl	Tamsulosin Hcl	309	109
Omeprazole	Omeprazole	283	97
Rosuvastatin Calcium	Rosuvastatin Calcium	244	73
Hydrochlorothiazide	Hydrochlorothiazide	240	71
Simvastatin	Simvastatin	225	66
Metformin Hcl Er	Metformin Hcl	218	75
Trazodone Hcl	Trazodone Hcl	211	78
Metoprolol Succinate	Metoprolol Succinate	188	61
Sertraline Hcl	Sertraline Hcl	165	57
Allopurinol	Allopurinol	161	50
Albuterol Sulfate Hfa	Albuterol Sulfate	133	73
Metformin Hcl	Metformin Hcl	132	43
Pregabalin	Pregabalin	131	54
Finasteride	Finasteride	128	41
Pantoprazole Sodium	Pantoprazole Sodium	99	34
Eliquis	Apixaban	93	33
Meloxicam	Meloxicam	92	37
Montelukast Sodium	Montelukast Sodium	89	24
Furosemide	Furosemide	88	38
Spironolactone	Spironolactone	85	27
Trulicity	Dulaglutide	83	17
Escitalopram Oxalate	Escitalopram Oxalate	82	25
Fluoxetine Hcl	Fluoxetine Hcl	81	26
Zolpidem Tartrate	Zolpidem Tartrate	81	27
Pravastatin Sodium	Pravastatin Sodium	76	21
Synthroid	Levothyroxine Sodium	75	21
Duloxetine Hcl	Duloxetine Hcl	73	19
Triamcinolone Acetonide	Triamcinolone Acetonide	73	40
Bupropion Xl	Bupropion Hcl	72	24
Fluticasone Propionate	Fluticasone Propionate	70	28
Tramadol Hcl	Tramadol Hcl	68	30
Prednisone	Prednisone	65	55
Citalopram Hbr	Citalopram Hydrobromide	62	18
Famotidine	Famotidine	61	21
Jardiance	Empagliflozin	59	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Ozempic	Semaglutide	57	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	54	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	51	19
Metoprolol Tartrate	Metoprolol Tartrate	49	20
Carvedilol	Carvedilol	48	15
Acyclovir	Acyclovir	44	15
Quetiapine Fumarate	Quetiapine Fumarate	42	11
Valacyclovir	Valacyclovir Hcl	42	28
Hydroxyzine Hcl	Hydroxyzine Hcl	41	20
Glipizide Er	Glipizide	40	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	17
Chlorthalidone	Chlorthalidone	38	12
Januvia	Sitagliptin Phosphate	38	13
Alprazolam	Alprazolam	37	19
Celecoxib	Celecoxib	37	14
Clopidogrel	Clopidogrel Bisulfate	37	11
Baclofen	Baclofen	36	19
Doxepin Hcl	Doxepin Hcl	36	14
Azelastine Hcl	Azelastine Hcl	35	21
Olmesartan Medoxomil	Olmesartan Medoxomil	35	suppressed
Potassium Chloride	Potassium Chloride	35	13
Benazepril Hcl	Benazepril Hcl	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Colchicine	Colchicine	33	20
Estradiol	Estradiol	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	11
Donepezil Hcl	Donepezil Hcl	32	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	13
Lorazepam	Lorazepam	30	19
Sumatriptan Succinate	Sumatriptan Succinate	29	suppressed
Cephalexin	Cephalexin	28	26
Glipizide	Glipizide	28	suppressed
Tizanidine Hcl	Tizanidine Hcl	28	suppressed
Mirtazapine	Mirtazapine	27	14
Valsartan	Valsartan	27	suppressed
Oxycodone Hcl	Oxycodone Hcl	26	14
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Arnuity Ellipta	Fluticasone Furoate	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	23
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	11
Ondansetron Odt	Ondansetron	20	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Farxiga	Dapagliflozin Propanediol	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Ketoconazole	Ketoconazole	19	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Atenolol	Atenolol	18	suppressed
Nystatin	Nystatin	18	suppressed
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Metronidazole	Metronidazole	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Naproxen	Naproxen	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Fluocinonide	Fluocinonide	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Amiloride Hcl	Amiloride Hcl	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Lactulose	Lactulose	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Ropinirole Er	Ropinirole Hcl	11	suppressed
Temazepam	Temazepam	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$36.57 · 2 records	Abbott Laboratories	FREESTYLE LIBRE 3, The Cologuard Plus Collection Kit	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error